
|Articles|January 29, 2021
YPrime Launches eCOA Gen 5
Advertisement
YPrime, LLC has announced the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform. YPrime’s newest platform features an improved user experience for patients, clinical investigators, sponsors, and CROs. YPrime’s platform aims to help patients remain engaged and compliant through straightforward design. They offer a customized solution with the necessary control and security that collects data from specification to submission.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Moving Beyond Historical Site Data to Real-Time Patient Insight
3
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
4
How Community Sites Can Stay Competitive Under Growing Efficiency Pressures
5



